Schedule 13D ownership disclosure
DelMar Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 247078108
Event date: 2014-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013762-14-001267
- Form type
- SC 13D
- Filer
- BACHA JEFFREY
- CIK
- CIK 1432149
- Filed
- Oct 31, 2014
- Reporting period
- Oct 28, 2014
- Description
- Schedule 13D beneficial ownership